To the central content area :::


Listed Companies

:::Listed Companies > Listed Companies Info. > Emerging Stock Board Companies > Listed Company Profile

ESM Companies

For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
6875 PBI
Basic information
Chairman President Spokesperson Telephone Address ESM Registration Date
WANG CHIEN CHIH KAN PEI KAN PEI (02)27827561 3F.-3, No. 66, Sanchong Rd., Nangang Dist.,Taipei City 115602 , Taiwan (R.O.C.) 2022/02/22
Key businesses
Biotechnology and Medical Care Pharmosa Biopharm Inc.(PBI) is a world-class biotechnology company focusing on developing a new drug by exploiting our proprietary formulation and manufacturing technology. With regional/global strategic partnerships,we commercialize our product through 505(b)2 or hybrid applications to regulatory authorities. Our Vision: We strive for excellence in order to improve quality of life for people through innovation and sustained quality. Our Mission: We expand the potential of existing drugs by exploiting innovative delivery formulations and medical devices,then bringing the combined medicines to patients and healthcare providers.
Market info
Latest trading info Historic trading info
Financial data
Cash flows statement Item
Amount(NTD, in thousands)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
balance sheet
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
profit and loss
Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 Investors may find more detailed information on the company by visiting the Market Observation Post System.。
 The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.